Your browser doesn't support javascript.
loading
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.
Xiang, Xiaogang; Feng, Dechun; Hwang, Seonghwan; Ren, Tianyi; Wang, Xiaolin; Trojnar, Eszter; Matyas, Csaba; Mo, Ruidong; Shang, Dabao; He, Yong; Seo, Wonhyo; Shah, Vijay H; Pacher, Pal; Xie, Qing; Gao, Bin.
Afiliação
  • Xiang X; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA; Department of Infectious Diseases, Translational Laboratory of Liver Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 20002
  • Feng D; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Hwang S; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Ren T; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Wang X; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Trojnar E; Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.
  • Matyas C; Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.
  • Mo R; Department of Infectious Diseases, Translational Laboratory of Liver Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shang D; Department of Infectious Diseases, Translational Laboratory of Liver Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • He Y; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Seo W; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Shah VH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Pacher P; Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.
  • Xie Q; Department of Infectious Diseases, Translational Laboratory of Liver Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: xieqingrjh@163.com.
  • Gao B; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA. Electronic address: bgao@mail.nih.gov.
J Hepatol ; 72(4): 736-745, 2020 04.
Article em En | MEDLINE | ID: mdl-31786256

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Klebsiella / Interleucinas / Doença Hepática Induzida por Substâncias e Drogas / Insuficiência Hepática Crônica Agudizada / Klebsiella pneumoniae / Regeneração Hepática Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Klebsiella / Interleucinas / Doença Hepática Induzida por Substâncias e Drogas / Insuficiência Hepática Crônica Agudizada / Klebsiella pneumoniae / Regeneração Hepática Idioma: En Ano de publicação: 2020 Tipo de documento: Article